IL60185A - 6 beta,7 beta;15,16-dimethylene-1,4-androstadien-3-ones,process for their production and pharmaceutical preparations containing them - Google Patents

6 beta,7 beta;15,16-dimethylene-1,4-androstadien-3-ones,process for their production and pharmaceutical preparations containing them

Info

Publication number
IL60185A
IL60185A IL60185A IL6018580A IL60185A IL 60185 A IL60185 A IL 60185A IL 60185 A IL60185 A IL 60185A IL 6018580 A IL6018580 A IL 6018580A IL 60185 A IL60185 A IL 60185A
Authority
IL
Israel
Prior art keywords
beta
androstadien
dimethylene
ones
production
Prior art date
Application number
IL60185A
Other languages
English (en)
Other versions
IL60185A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL60185A0 publication Critical patent/IL60185A0/xx
Publication of IL60185A publication Critical patent/IL60185A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Control Of High-Frequency Heating Circuits (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
IL60185A 1979-05-31 1980-05-29 6 beta,7 beta;15,16-dimethylene-1,4-androstadien-3-ones,process for their production and pharmaceutical preparations containing them IL60185A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792922500 DE2922500A1 (de) 1979-05-31 1979-05-31 6 beta .7 beta

Publications (2)

Publication Number Publication Date
IL60185A0 IL60185A0 (en) 1980-07-31
IL60185A true IL60185A (en) 1983-06-15

Family

ID=6072347

Family Applications (1)

Application Number Title Priority Date Filing Date
IL60185A IL60185A (en) 1979-05-31 1980-05-29 6 beta,7 beta;15,16-dimethylene-1,4-androstadien-3-ones,process for their production and pharmaceutical preparations containing them

Country Status (16)

Country Link
US (1) US4291029A (da)
EP (1) EP0019690B1 (da)
JP (1) JPS55162799A (da)
AT (1) ATE880T1 (da)
AU (1) AU531057B2 (da)
CA (1) CA1134814A (da)
CS (1) CS214712B2 (da)
DD (1) DD151172A5 (da)
DE (2) DE2922500A1 (da)
DK (1) DK145140C (da)
ES (1) ES8101082A1 (da)
HU (2) HU181714B (da)
IE (1) IE49899B1 (da)
IL (1) IL60185A (da)
SU (1) SU873890A3 (da)
YU (1) YU41926B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111951A1 (de) * 1981-03-23 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen 7(alpha)-alkoxycarbonyl-15ss-methylen-4-androstene, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3213962A1 (de) * 1982-04-13 1983-10-13 Schering AG, 1000 Berlin und 4709 Bergkamen 1(alpha).2(alpha);6(beta).7(beta).15(beta).16(beta)-trimethylen-3-oxo-17(alpha)-pregn-4-en-21.17-carbolacton, dessen herstellung und verwendung als arzneimittel
DE3222265A1 (de) * 1982-06-09 1983-12-15 Schering AG, 1000 Berlin und 4709 Bergkamen 6ss.7ss-methylen-17(alpha)-pregn-4-en-21.17-carbolactone, verfahren zu ihrer herstellung und verwendung als arzneimittel
JPS5921698A (ja) * 1982-07-22 1984-02-03 シエ−リング・アクチエンゲゼルシヤフト １７α−プレグネ−４−エン−３−オキソ−２１−カルボン酸エステル、その製法およびこれを含有する抗アンドロゲン作用を有する医薬
DE3227598A1 (de) * 1982-07-22 1984-01-26 Schering AG, 1000 Berlin und 4709 Bergkamen 7(alpha)-acylthio-15.16-methylen-3-oxo-17(alpha)-pregna-1.4-dien-21,17-carbolactone, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3240510A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 7(alpha)-acylthio-1(alpha),2(alpha)-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, deren herstellung und diese enthaltende arzneimittel
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
DE3326013A1 (de) * 1983-07-15 1985-01-24 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-methylen-17(alpha)-pregna-4,6-dien-21-carbonsaeuresalze, diese enthaltende pharmazeutische praeparate sowie verfahren zu deren herstellung
DE3481707D1 (de) * 1983-08-17 1990-04-26 Schering Ag 7-alpha-substituierte 3-oxo-17alpha-pregn-4-en-21.17-carbolactone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
FR2697328A1 (fr) * 1992-10-23 1994-04-29 Giat Ind Sa Munition fumigène.
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
DE102007027636A1 (de) * 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027635A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063501A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15, 16-Methylen-17-hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063500A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063498A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063496A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063499A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft Steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063495A1 (de) 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
DE102008026793A1 (de) 2008-06-02 2009-12-03 Bayer Schering Pharma Aktiengesellschaft C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
TW201322986A (zh) 2011-11-04 2013-06-16 拜耳製藥公司 １８－甲基－６，７－亞甲基－３－氧基－１７－妊－４－烯－２１，１７β－羧內酯、包含該化合物之醫療製劑及其於治療子宮內膜異位症之用途
WO2016063269A1 (en) 2014-10-20 2016-04-28 Prendergast Patrick T Use of antagonists to the nuclear steroid receptor alone or in combination as direct antiviral agents to inhibit alphavirus, togaviridae, arenaviridae, filoviridae, bunyaviridae, flaviviridae and rhabdoviridae

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254074A (en) * 1962-04-25 1966-05-31 Merck & Co Inc Spiroxenones
DE2264189C3 (de) * 1972-12-29 1979-05-31 Merck & Co., Inc., Rahway, N.J. (V.St.A.) 3'-(3-Oxo-17beta-hydroxy-6,7-methylen-androst-4en-bzw.-l,4-dien-17 a-yl) -propionsäureverbindungen, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
ES469510A1 (es) * 1977-05-16 1978-12-01 Schering Ag Procedimiento para la preparacion de 17beta hidroxi-4-an- drosten-3-onas.

Also Published As

Publication number Publication date
IE49899B1 (en) 1986-01-08
YU41926B (en) 1988-02-29
DD151172A5 (de) 1981-10-08
DK145140C (da) 1983-02-21
DK145140B (da) 1982-09-13
HU187419B (en) 1986-01-28
ES491916A0 (es) 1980-12-16
IL60185A0 (en) 1980-07-31
YU132980A (en) 1983-02-28
DK234780A (da) 1980-12-01
AU5874580A (en) 1980-12-04
ATE880T1 (de) 1982-05-15
SU873890A3 (ru) 1981-10-15
JPS55162799A (en) 1980-12-18
CS214712B2 (en) 1982-05-28
EP0019690B1 (de) 1982-04-21
DE3060297D1 (en) 1982-06-03
ES8101082A1 (es) 1980-12-16
US4291029A (en) 1981-09-22
CA1134814A (en) 1982-11-02
EP0019690A1 (de) 1980-12-10
HU181714B (en) 1983-11-28
IE801127L (en) 1980-11-30
JPH0214360B2 (da) 1990-04-06
DE2922500A1 (de) 1980-12-04
AU531057B2 (en) 1983-08-11

Similar Documents

Publication Publication Date Title
IL60185A (en) 6 beta,7 beta;15,16-dimethylene-1,4-androstadien-3-ones,process for their production and pharmaceutical preparations containing them
GB2050828B (en) Process for the preparations of finely divided pharmaceutical compositions
ZA848651B (en) Novel polypeptides with an alpha-amylase-inhibiting action,a process for their preparation,their use and pharmaceutical products
GR3004925T3 (da)
HUT39419A (en) Process for preparing tetraline derivatives
DE2967610D1 (en) Pyrimido (6,1-a) isoquinolin-4-ones, process for their preparation and their application in medicaments; intermediates and their preparation
DE2966179D1 (en) Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same
ZA821660B (en) N-(2,2,2-trifluoroethyl)-n-alkyl-azolyloxyacetic acid amides, a process for their preparation and their use as herbicides, and new intermediate products for their preparation
RO80320A (ro) Procedeu de preparare a unui compozitii insecticide si nematocide
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
BE881754A (fr) Procede de preparation d'anilines metachlorees
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
PH24207A (en) 2-acylamino-6-amino-4,5,6,7-tetrahydrobenzothiazoles
EP0301371A3 (en) Benzofuran carboxamides with basic substituents, process for their preparation and therapeutical compositions containing them
DE3264007D1 (en) 5,6-dihydro-11-alkylene-morphantridin-6-ones, process for their preparation and pharmaceutical preparations containing them
IL60268A0 (en) Process for the preparation of 3,3-dimethyl-cyclopropane-1,1,2-tricarboxylic acid derivatives,and -halogeno-nitriles as new intermediate products for this process and their preparation
PT72086B (en) Process for the preparation of 5,10-dihydro-imydazoi (2,1-b)quinazolines with pharmaceutical effect
DK92183A (da) 11beta-chlor-delta15-steroider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater med indhold heraf
PT70584A (en) Process of synthesis for the preparation of substituted 2-phenylamino-imidazoline-(2)with particular pharmaceutical properties
FR2462412B1 (fr) Procede de preparation d'anisaldehyde
ZA803402B (en) Process for the preparation of 3,3-dimethyl-allyl alcohol
PT70367A (en) Process for the preparation of 4,4-dimethyl-4-sila-fatty acid amides with pharmaceutical effect
ES8705401A1 (es) Un procedimiento para la obtencion de 1.4-dihidropirazinas
ZA881322B (en) Benzylaminoaryl-dihydropyridinelactones,process for their preparation,and their use in medicaments